心通醫療(02160.HK)主動脈瓣植入術產品VitaFlow Liberty於泰國註冊

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

心通醫療(02160.HK)主動脈瓣植入術產品VitaFlow Liberty於泰國註冊

阿思達克 02-22 00:54

心通醫療－Ｂ(02160.HK)公布，公司自主研發的新一代經導管主動脈瓣植入術「TAVI」產品VitaFlow Liberty經導管主動脈瓣植入系統及Alwide Plus球囊導管於泰國成功註冊，標誌公司國際化佈局的進一步深化。 2021年8月，VitaFlow Liberty獲中國國家藥監局註冊批准後，快速滲透全國合資格手術中心，市場份額不斷提升。其歐盟CE標誌註冊亦處於審評階段。

心通醫療-B(02160.HK)

Relevant Stocks

心通醫療-B(02160.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

心通醫療(02160.HK)主動脈瓣植入術產品VitaFlow Liberty於泰國註冊

Services

About Us

Agreement Statement